Article info
Adverse drug reactions
Terbinafine-induced Steven-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) overlap
- Correspondence to Abheek Sil, Department of Dermatology, Venereology, and Leprosy, R.G. Kar Medical College, 1, Khudiram Bose Sarani, Kolkata 700004, West Bengal, India; abheek.sil{at}gmail.com
Citation
Terbinafine-induced Steven-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) overlap
Publication history
- Received May 26, 2020
- Accepted June 13, 2020
- First published July 14, 2020.
Online issue publication
September 28, 2021
Article Versions
- Previous version (14 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.